75957-60-7 Usage
General Description
SP-5 is a potent synthetic chemical compound that belongs to the class of cathinones, a type of synthetic stimulants known for their psychoactive effects. It acts as a potent and highly selective serotonin and norepinephrine-reuptake inhibitor, leading to increased levels of these neurotransmitters in the brain. The compound is primarily known for its stimulant and psychoactive effects, including increased energy, euphoria, and enhanced cognitive and physical performance. It has also been associated with adverse side effects such as agitation, tachycardia, and hypertension. Due to its potent effects and potential for abuse, SP-5 is a controlled substance in many countries and is subject to legal restrictions.
Check Digit Verification of cas no
The CAS Registry Mumber 75957-60-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,5,9,5 and 7 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 75957-60:
(7*7)+(6*5)+(5*9)+(4*5)+(3*7)+(2*6)+(1*0)=177
177 % 10 = 7
So 75957-60-7 is a valid CAS Registry Number.
InChI:InChI=1/C31H51N9O9/c1-17(2)25(29(47)39-23(30(48)49)16-18-8-10-19(41)11-9-18)40-28(46)22(12-13-24(42)43)38-27(45)21(7-3-4-14-32)37-26(44)20(33)6-5-15-36-31(34)35/h8-11,17,20-23,25,41H,3-7,12-16,32-33H2,1-2H3,(H,37,44)(H,38,45)(H,39,47)(H,40,46)(H,42,43)(H,48,49)(H4,34,35,36)/t20-,21-,22-,23-,25-/m0/s1
75957-60-7Relevant articles and documents
Peptides having thymopoietin-like activity
-
, (2008/06/13)
There are disclosed peptides having the following formula: 1 wherein A is STR1 X is a suitable neutral, aliphatic or aromatic amino acid residue; e.g., one selected from the group consisting of ALA, 2-Me-ALA, GLY, LEU, ILE, LYS, THR, SER, PHE, MET, D-ALA, D-LEU, D-ILE, D-LYS, D-THR, allo-THR, D-SER, D-PHE, D-MET, and SAR; Z is STR2 Y is GLY, SER, THR, LEU, ILE, VAl, or SAR; B is TYR-R', D-TYR-R', decarboxy-TYR, or STR3 m is 3 or 4; n is 1, 2, or 3; R''' is hydrogen, C1 -C7 alkyl, C6 -C12 aryl, or C1 -C7 alkanoyl; and R and R' are substituents which do not substantially affect the biological activity of the peptides, provided that R-ARG-LYS-ASP-VAL-TYR-R' is excluded. These peptides have the capability of inducing the differentiation of T-lymphocytes but not of complement receptor (CR+) B-lymphocytes and thus are useful in a number of therapeutic areas. Also provided are derivatives of the peptides, therapeutic compositions, and methods for use of the compositions.
